Can patient navigators and At-Home tests boost cervical cancer screening?
NCT ID NCT06943547
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in Puerto Rico tests whether patient navigators (who help women overcome barriers like transportation) and at-home HPV self-testing can increase cervical cancer screening. About 1,400 women aged 25-65 who are overdue for screening will be randomly assigned to different support strategies. The goal is to find cost-effective ways to catch cancer early and reduce health disparities.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that patient navigators and at-home HPV tests boost screening rates and reduce cervical cancer disparities in Puerto Rico.
- What could go wrong
- This is an early-stage behavioral study, not testing a new drug or cure. Results may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,400 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 25-65 years old * No history of cervical cancer or hysterectomy * Have not had a Pap test in the past 3 years or more, an HPV test in the past 5 years or more, or a combination of a Pap test and an HPV test in the past 5 or more years (co-testing). * Must have a record at the study clinics (at least 2 previous visits). Exclusion Criteria: * Women with no telephone contact information * Being pregnant\* * Living with HIV, Lupus, or Crohn's\* * Active on immunotherapy treatment\* * History of organ transplants\* * Will be excluded as cervical cancer screening guidelines differ for them.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical cancer screening are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Puerto Rico
San Juan, PR, 00927, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cervical smear DNA may reveal ovarian cancer years before symptoms
- Can a virtual promotora get more hispanic women screened for cervical cancer?
- A digital coach may guide patients through cervical cancer prevention
- Self-swabs could boost cervical cancer screening in kazakhstan
- Self-sampling for cervical cancer screening could make testing easier and more accessible
- Self-Sampling could boost cervical cancer screening for women with HIV